HIGHLIGHTS
- who: Stuti Khadka from the National Institute of Genomic Medicine (INMEGEN), Mexico University of Birmingham, United Kingdom have published the article: Glucocorticoid regulation of cancer development and progression, in the Journal: (JOURNAL)
- what: Glucocorticoid signaling is highly divergent across different cancer types, and their effects significantly change as cancers develop.
- future: The exact effects of glucocorticoids likely vary depending on tumor type and much more work is needed to fully elucidate how glucocorticoid adjuvant therapies affect various cancer types. Investigation is needed to uncover how glucocorticoid signaling during H. pylori infection affects gastric . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.